Clinical and radiological efficacy of a new conservative treatment for fibrocystic disease
Background. Long-lasting dyshormonal breast diseases in women represent a risk factor for breast cancer, especially in patients with atypia. Clinical manifestations of fibrocystic breast disease (FBD) and mastopathy, including high-intensity pain cause psychoemotional discomfort and reduce the quali...
Saved in:
Main Authors: | R. M. Shabaev (Author), I. V. Kolyadina (Author), D. A. Blagovestnov (Author), P. M. Starokon (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors for breast cancer in patients with benign breast diseases: a 10-year observational study
by: R. M. Shabaev, et al.
Published: (2024) -
Cystic fibrosis or fibrocystic disease: The sweat test for fibrocystic disease
by: T. Dreyer
Published: (1967) -
CURRENT POTENTIALITIES OF THERAPY FOR FIBROCYSTIC DISEASE
by: I. V. Vysotskaya
Published: (2014) -
Basic therapy in the treatment of diffuse fibrocystic mastopathy
by: I. V. Vysotskaya
Published: (2014) -
The effect of Metformin on fibrocystic breast disease in women with insulin resistance
by: E. V. Musina, et al.
Published: (2018)